There are reports stating that Parabolic Drugs is in talks with Japanese firms for bulk supply deals. In an interview to CNBC-TV18, Vineet Gupta, director of Parabolic Drugs confirmed the same.
However, he said, these are little early days. “We have signed some supply contracts, both in API supply and in CRAMs space and the process of liquidation is on. However, supply will start once this process gets over.”
back
No comments:
Post a Comment